The changing landscape for surgical sealants, glues, hemostats, other wound closure and anti-adhesion

Products that provide hemostasis, closure, sealing and anti-adhesion of wounds comprised long established products (e.g., tapes, sutures, etc.) as well as a variety of advanced products such as fibrin and other surgical sealants, surgical glues, hemostats and products to prevent post-surgical adhesion. While traditional products are being innovated to keep pace with advanced products (for example, through the development of absorbable sutures), the shift of caseload and product sales away from traditional products appears unrelenting.

As a result, the balance of the competitive landscape is forecast to shift over the next few years toward advanced sealing, hemostasis, closure and anti-adhesion products. Below is illustrated, in a combined “donut” chart, this shift from 2012 to 2017 in the share of the global market for these products.

About P. Driscoll

Patrick Driscoll founded MedMarket Diligence and has become a leading source of analysis and insight in medical technology markets. He previously co-founded Medtech Insight and was a principal at Medical Data International. He has 25 years of experience assessing current and potential markets for medical technologies.

Post navigation

MMD Reports

We value our blog readers, and to show it, we offer them a 10% discount off MedMarket Diligence Report purchases or Startups subscriptions. Order online and, at checkout, enter the coupon code "1367694907" for the discount!